Clinical data suggests tirzepatide produces slightly greater average weight loss than semaglutide, but the difference is not enormous, and some patients respond better to one medication than the other
Both platforms support patients for as long as clinically appropriate, with most patients continuing therapy for 12-24 months or longer
If you already have a job, your boss knows how well you can work
TJs, composed of claudins, occludin, junctional adhesion molecules (JAMs), and the zonula occludin (ZO) family, are believed to regulate vascular paracellular transport by forming a high-resistance electrical barrier [17]
Clinical and real-world evidence delivered in a consumer-friendly manner expands the audience and use of research
GLP-1s Arent a One-Size-Fits-All Solution Experts stress that the results should not be interpreted as proof that everyone with obesity and an autoimmune disease should take a GLP-1 medication